We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A series of FDA recalls on “sartan” active ingredients made abroad has shaken the drug industry’s confidence in the manufacturing process used for the generic blood pressure medications.
After the latest round of tariff war escalation, nearly all U.S. medtech exports to China are now subject to additional tariffs. Takeda's Alunbrig triumphed over Pfizer's Xalkori in a head-to-head first-line ALK-positive lung ...
Mainland-traded pharma stock prices rise 10pc as a sector in 2018 so far, the best-performing industry on the CSI 300 Index. China's pharmaceutical industry is poised for major growth.